Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diethylstilbestrol | 29 | 2024 | 49 | 4.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 27 | 2021 | 151 | 3.690 |
Why?
|
| Estrogens, Non-Steroidal | 16 | 2020 | 35 | 1.700 |
Why?
|
| Breast Neoplasms | 13 | 2018 | 1118 | 1.130 |
Why?
|
| Pregnancy | 38 | 2024 | 2202 | 0.940 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2024 | 135 | 0.920 |
Why?
|
| Maternal Exposure | 5 | 2019 | 39 | 0.740 |
Why?
|
| Fetal Blood | 5 | 2016 | 70 | 0.710 |
Why?
|
| Mammography | 3 | 2018 | 269 | 0.680 |
Why?
|
| Breast Density | 1 | 2018 | 16 | 0.590 |
Why?
|
| Neoplasms | 5 | 2021 | 1240 | 0.560 |
Why?
|
| Medical Assistance | 1 | 2016 | 10 | 0.550 |
Why?
|
| Culturally Competent Care | 1 | 2016 | 15 | 0.540 |
Why?
|
| Pathology, Clinical | 1 | 2016 | 21 | 0.540 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2018 | 28 | 0.430 |
Why?
|
| Follow-Up Studies | 13 | 2024 | 2337 | 0.400 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 705 | 0.400 |
Why?
|
| Carcinogens | 3 | 2017 | 37 | 0.390 |
Why?
|
| Risk | 7 | 2021 | 364 | 0.390 |
Why?
|
| Mass Screening | 2 | 2016 | 645 | 0.390 |
Why?
|
| Menopause | 3 | 2013 | 249 | 0.380 |
Why?
|
| Smoking | 2 | 2008 | 826 | 0.370 |
Why?
|
| Pre-Eclampsia | 4 | 2014 | 69 | 0.370 |
Why?
|
| Female | 41 | 2024 | 30694 | 0.340 |
Why?
|
| Adult | 28 | 2019 | 15662 | 0.330 |
Why?
|
| Blood Cell Count | 2 | 2016 | 32 | 0.330 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2008 | 276 | 0.320 |
Why?
|
| Middle Aged | 20 | 2021 | 16310 | 0.320 |
Why?
|
| Birth Weight | 2 | 2010 | 81 | 0.300 |
Why?
|
| Autoimmune Diseases | 1 | 2010 | 220 | 0.300 |
Why?
|
| Incidence | 7 | 2021 | 1236 | 0.300 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2008 | 29 | 0.290 |
Why?
|
| Maternal Welfare | 1 | 2008 | 15 | 0.290 |
Why?
|
| Endocrine Disruptors | 2 | 2019 | 73 | 0.290 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2008 | 57 | 0.280 |
Why?
|
| Papanicolaou Test | 3 | 2016 | 42 | 0.280 |
Why?
|
| Vaginal Smears | 3 | 2016 | 54 | 0.280 |
Why?
|
| Attitude to Health | 2 | 2015 | 279 | 0.280 |
Why?
|
| Humans | 42 | 2024 | 59280 | 0.270 |
Why?
|
| Environmental Exposure | 1 | 2008 | 208 | 0.260 |
Why?
|
| Cohort Studies | 13 | 2020 | 2372 | 0.250 |
Why?
|
| Menstruation Disturbances | 2 | 2018 | 18 | 0.220 |
Why?
|
| Premature Birth | 2 | 2018 | 108 | 0.220 |
Why?
|
| Case-Control Studies | 4 | 2020 | 1050 | 0.210 |
Why?
|
| Osteoporosis | 2 | 2013 | 102 | 0.200 |
Why?
|
| Menarche | 2 | 2013 | 35 | 0.200 |
Why?
|
| Sexual Behavior | 2 | 2020 | 189 | 0.200 |
Why?
|
| Young Adult | 8 | 2018 | 4266 | 0.200 |
Why?
|
| Prospective Studies | 5 | 2024 | 3065 | 0.180 |
Why?
|
| Gallbladder Diseases | 1 | 2020 | 26 | 0.180 |
Why?
|
| Surveys and Questionnaires | 11 | 2017 | 2511 | 0.180 |
Why?
|
| Pancreatic Neoplasms | 2 | 2020 | 331 | 0.170 |
Why?
|
| Stem Cells | 2 | 2016 | 255 | 0.160 |
Why?
|
| Gender Identity | 1 | 2020 | 62 | 0.160 |
Why?
|
| Infertility, Female | 3 | 2008 | 44 | 0.160 |
Why?
|
| Risk Factors | 9 | 2019 | 4982 | 0.160 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2016 | 28 | 0.150 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 788 | 0.150 |
Why?
|
| Male | 14 | 2021 | 27726 | 0.140 |
Why?
|
| Academic Medical Centers | 2 | 2016 | 306 | 0.140 |
Why?
|
| Volunteers | 1 | 2016 | 16 | 0.140 |
Why?
|
| Prognosis | 2 | 2018 | 1599 | 0.140 |
Why?
|
| Medically Uninsured | 1 | 2016 | 39 | 0.130 |
Why?
|
| Medically Underserved Area | 1 | 2016 | 28 | 0.130 |
Why?
|
| Age Factors | 5 | 2016 | 1504 | 0.130 |
Why?
|
| Boston | 1 | 2016 | 246 | 0.130 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 84 | 0.130 |
Why?
|
| Cervix Uteri | 1 | 2016 | 56 | 0.130 |
Why?
|
| Genetic Counseling | 1 | 2015 | 15 | 0.120 |
Why?
|
| Genetics, Medical | 1 | 2015 | 11 | 0.120 |
Why?
|
| Vaginal Neoplasms | 1 | 2015 | 3 | 0.120 |
Why?
|
| Fetal Stem Cells | 1 | 2014 | 3 | 0.120 |
Why?
|
| Verbal Behavior | 1 | 2014 | 36 | 0.120 |
Why?
|
| Colposcopy | 1 | 2014 | 20 | 0.120 |
Why?
|
| Adolescent | 7 | 2018 | 5822 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2016 | 335 | 0.110 |
Why?
|
| Health Communication | 1 | 2014 | 32 | 0.110 |
Why?
|
| United States | 9 | 2018 | 7384 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 635 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 236 | 0.110 |
Why?
|
| Menstruation | 1 | 2013 | 31 | 0.110 |
Why?
|
| Blood Proteins | 1 | 2013 | 75 | 0.110 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 53 | 0.100 |
Why?
|
| Parity | 2 | 2015 | 70 | 0.100 |
Why?
|
| Proportional Hazards Models | 6 | 2013 | 674 | 0.100 |
Why?
|
| Pain Management | 1 | 2014 | 146 | 0.100 |
Why?
|
| Depression | 1 | 2019 | 828 | 0.100 |
Why?
|
| Umbilical Arteries | 1 | 2012 | 9 | 0.100 |
Why?
|
| Ultrasonography, Doppler | 1 | 2012 | 24 | 0.100 |
Why?
|
| Infant, Newborn | 4 | 2014 | 1283 | 0.100 |
Why?
|
| Fetal Growth Retardation | 1 | 2012 | 14 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 323 | 0.100 |
Why?
|
| Proteomics | 1 | 2013 | 263 | 0.100 |
Why?
|
| Genital Neoplasms, Female | 1 | 2011 | 17 | 0.090 |
Why?
|
| Pain | 1 | 2014 | 396 | 0.090 |
Why?
|
| Fetal Development | 1 | 2010 | 16 | 0.090 |
Why?
|
| Breast | 2 | 2016 | 173 | 0.080 |
Why?
|
| Physicians | 1 | 2015 | 426 | 0.080 |
Why?
|
| Aged | 4 | 2020 | 13411 | 0.080 |
Why?
|
| Urogenital Abnormalities | 1 | 2009 | 10 | 0.080 |
Why?
|
| Hysterosalpingography | 1 | 2008 | 3 | 0.080 |
Why?
|
| Fallopian Tube Diseases | 1 | 2008 | 5 | 0.080 |
Why?
|
| Exercise | 1 | 2016 | 883 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 515 | 0.070 |
Why?
|
| Sex Ratio | 1 | 2007 | 8 | 0.070 |
Why?
|
| Genitalia, Male | 1 | 2007 | 9 | 0.070 |
Why?
|
| Growth Substances | 1 | 2007 | 34 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 364 | 0.070 |
Why?
|
| Risk-Taking | 1 | 2008 | 158 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 322 | 0.070 |
Why?
|
| Hormones | 1 | 2007 | 60 | 0.070 |
Why?
|
| Estrogens | 1 | 2007 | 109 | 0.070 |
Why?
|
| Estradiol Congeners | 1 | 2006 | 2 | 0.070 |
Why?
|
| Odds Ratio | 4 | 2010 | 745 | 0.070 |
Why?
|
| Gestational Age | 3 | 2012 | 178 | 0.060 |
Why?
|
| Hysterectomy, Vaginal | 1 | 2005 | 11 | 0.060 |
Why?
|
| Uterine Prolapse | 1 | 2005 | 13 | 0.060 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2017 | 8 | 0.060 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2005 | 41 | 0.060 |
Why?
|
| Genitalia | 1 | 2024 | 9 | 0.060 |
Why?
|
| Neoplastic Stem Cells | 1 | 2006 | 196 | 0.060 |
Why?
|
| Disease Susceptibility | 2 | 2014 | 157 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2016 | 639 | 0.050 |
Why?
|
| Logistic Models | 3 | 2015 | 1232 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2003 | 133 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2003 | 197 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2024 | 266 | 0.050 |
Why?
|
| Testicular Neoplasms | 1 | 2001 | 32 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2008 | 1920 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1189 | 0.040 |
Why?
|
| Child | 3 | 2018 | 4173 | 0.040 |
Why?
|
| Health Surveys | 2 | 2015 | 298 | 0.040 |
Why?
|
| Nuclear Family | 2 | 2009 | 17 | 0.040 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2018 | 33 | 0.040 |
Why?
|
| Reproduction | 1 | 2018 | 89 | 0.040 |
Why?
|
| Sex Factors | 1 | 2001 | 935 | 0.040 |
Why?
|
| Endometrial Neoplasms | 1 | 2017 | 53 | 0.030 |
Why?
|
| Self Report | 1 | 2019 | 359 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 255 | 0.030 |
Why?
|
| Animals | 3 | 2010 | 19601 | 0.030 |
Why?
|
| Preconception Care | 1 | 2015 | 23 | 0.030 |
Why?
|
| Knowledge | 1 | 2015 | 30 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 169 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2019 | 6070 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 191 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 126 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 527 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 741 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 68 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 1305 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 295 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 40 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2015 | 396 | 0.020 |
Why?
|
| Stillbirth | 1 | 2011 | 17 | 0.020 |
Why?
|
| Menopause, Premature | 1 | 2011 | 25 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 5127 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 914 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2089 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2014 | 5283 | 0.020 |
Why?
|
| Cryptorchidism | 1 | 2009 | 8 | 0.020 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2009 | 14 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 1464 | 0.020 |
Why?
|
| Fallopian Tube Patency Tests | 1 | 2008 | 1 | 0.020 |
Why?
|
| Health Behavior | 1 | 2011 | 451 | 0.020 |
Why?
|
| Urogenital Neoplasms | 1 | 2008 | 4 | 0.020 |
Why?
|
| Leukemia | 1 | 2008 | 57 | 0.020 |
Why?
|
| Medical Records | 1 | 2008 | 133 | 0.020 |
Why?
|
| Reproductive History | 1 | 2007 | 15 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2008 | 95 | 0.020 |
Why?
|
| Uterus | 1 | 2007 | 39 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2007 | 57 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2007 | 20 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2007 | 241 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2007 | 84 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2007 | 485 | 0.020 |
Why?
|
| Ligaments | 1 | 2005 | 11 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2007 | 341 | 0.020 |
Why?
|
| Cell Division | 1 | 2007 | 443 | 0.020 |
Why?
|
| Phosphatidic Acids | 1 | 1983 | 7 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2006 | 384 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1983 | 49 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2006 | 357 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2008 | 1782 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2008 | 2373 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2005 | 426 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1983 | 283 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 3614 | 0.010 |
Why?
|
| Insulin | 1 | 1983 | 674 | 0.010 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 1983 | 4 | 0.000 |
Why?
|
| Glycogen Synthase | 1 | 1983 | 4 | 0.000 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1983 | 14 | 0.000 |
Why?
|
| Type C Phospholipases | 1 | 1983 | 33 | 0.000 |
Why?
|
| Oxytocin | 1 | 1983 | 45 | 0.000 |
Why?
|
| Adenosine | 1 | 1983 | 69 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1983 | 469 | 0.000 |
Why?
|
| Rats | 1 | 1983 | 1909 | 0.000 |
Why?
|